ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sabin Inactivated Polio vaccine (sIPV) Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-25T10553
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2022
BUY CHAPTERS

Global Sabin Inactivated Polio vaccine (sIPV) Market Research Report 2025

Code: QYRE-Auto-25T10553
Report
February 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biokangtai
Sinovac
Intravacc
Imbcams
Beijing Biological

Sabin Inactivated Polio vaccine (sIPV) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sabin Inactivated Polio vaccine (sIPV) Market

Sabin Inactivated Polio vaccine (sIPV) Market

The global market for Sabin Inactivated Polio vaccine (sIPV) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sabin Inactivated Polio vaccine (sIPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sabin Inactivated Polio vaccine (sIPV).
The Sabin Inactivated Polio vaccine (sIPV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sabin Inactivated Polio vaccine (sIPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sabin Inactivated Polio vaccine (sIPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sabin Inactivated Polio vaccine (sIPV) Market Report

Report Metric Details
Report Name Sabin Inactivated Polio vaccine (sIPV) Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biokangtai, Sinovac, Imbcams, Intravacc, Beijing Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sabin Inactivated Polio vaccine (sIPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sabin Inactivated Polio vaccine (sIPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Sabin Inactivated Polio vaccine (sIPV) Market report?

Ans: The main players in the Sabin Inactivated Polio vaccine (sIPV) Market are Biokangtai, Sinovac, Imbcams, Intravacc, Beijing Biological

What are the Application segmentation covered in the Sabin Inactivated Polio vaccine (sIPV) Market report?

Ans: The Applications covered in the Sabin Inactivated Polio vaccine (sIPV) Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sabin Inactivated Polio vaccine (sIPV) Market report?

Ans: The Types covered in the Sabin Inactivated Polio vaccine (sIPV) Market report are Vials, Syringes

Recommended Reports

Vaccine Markets

Vaccine Components

Inactivated & Viral Vaccines

1 Sabin Inactivated Polio vaccine (sIPV) Market Overview
1.1 Product Definition
1.2 Sabin Inactivated Polio vaccine (sIPV) by Type
1.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vials
1.2.3 Syringes
1.3 Sabin Inactivated Polio vaccine (sIPV) by Application
1.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Estimates and Forecasts
1.4.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue 2020-2031
1.4.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales 2020-2031
1.4.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sabin Inactivated Polio vaccine (sIPV) Market Competition by Manufacturers
2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sabin Inactivated Polio vaccine (sIPV), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Product Type & Application
2.7 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Date of Enter into This Industry
2.8 Global Sabin Inactivated Polio vaccine (sIPV) Market Competitive Situation and Trends
2.8.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sabin Inactivated Polio vaccine (sIPV) Players Market Share by Revenue
2.8.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sabin Inactivated Polio vaccine (sIPV) Market Scenario by Region
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2020-2031
3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2020-2025
3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2026-2031
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2020-2031
3.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2020-2025
3.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2026-2031
3.4 North America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.4.1 North America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2031)
3.4.3 North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.5.1 Europe Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2031)
3.5.3 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Region
3.6.1 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2020-2031)
3.6.3 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.7.1 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2031)
3.7.3 Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2020-2031)
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2020-2025)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2026-2031)
4.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2020-2031)
4.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2020-2031)
4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2020-2025)
4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2026-2031)
4.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2020-2031)
4.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2020-2031)
5.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2020-2025)
5.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2026-2031)
5.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2020-2031)
5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2020-2031)
5.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2020-2025)
5.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2026-2031)
5.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2020-2031)
5.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biokangtai
6.1.1 Biokangtai Company Information
6.1.2 Biokangtai Description and Business Overview
6.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.1.5 Biokangtai Recent Developments/Updates
6.2 Sinovac
6.2.1 Sinovac Company Information
6.2.2 Sinovac Description and Business Overview
6.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.2.5 Sinovac Recent Developments/Updates
6.3 Imbcams
6.3.1 Imbcams Company Information
6.3.2 Imbcams Description and Business Overview
6.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Imbcams Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.3.5 Imbcams Recent Developments/Updates
6.4 Intravacc
6.4.1 Intravacc Company Information
6.4.2 Intravacc Description and Business Overview
6.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Intravacc Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.4.5 Intravacc Recent Developments/Updates
6.5 Beijing Biological
6.5.1 Beijing Biological Company Information
6.5.2 Beijing Biological Description and Business Overview
6.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.5.5 Beijing Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sabin Inactivated Polio vaccine (sIPV) Industry Chain Analysis
7.2 Sabin Inactivated Polio vaccine (sIPV) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sabin Inactivated Polio vaccine (sIPV) Production Mode & Process Analysis
7.4 Sabin Inactivated Polio vaccine (sIPV) Sales and Marketing
7.4.1 Sabin Inactivated Polio vaccine (sIPV) Sales Channels
7.4.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
7.5 Sabin Inactivated Polio vaccine (sIPV) Customer Analysis
8 Sabin Inactivated Polio vaccine (sIPV) Market Dynamics
8.1 Sabin Inactivated Polio vaccine (sIPV) Industry Trends
8.2 Sabin Inactivated Polio vaccine (sIPV) Market Drivers
8.3 Sabin Inactivated Polio vaccine (sIPV) Market Challenges
8.4 Sabin Inactivated Polio vaccine (sIPV) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Biokangtai
Sinovac
Intravacc
Imbcams
Beijing Biological
List of Tables
 Table 1. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sabin Inactivated Polio vaccine (sIPV) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sabin Inactivated Polio vaccine (sIPV) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sabin Inactivated Polio vaccine (sIPV) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sabin Inactivated Polio vaccine (sIPV), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Product Type & Application
 Table 12. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sabin Inactivated Polio vaccine (sIPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sabin Inactivated Polio vaccine (sIPV) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2020-2025)
 Table 19. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2026-2031)
 Table 21. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2020-2025)
 Table 23. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2026-2031)
 Table 25. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Type (2020-2025)
 Table 51. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Type (2026-2031)
 Table 52. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2020-2025)
 Table 53. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2026-2031)
 Table 54. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2020-2025)
 Table 57. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2026-2031)
 Table 58. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Application (2020-2025)
 Table 61. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Application (2026-2031)
 Table 62. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2020-2025)
 Table 63. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2026-2031)
 Table 64. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2020-2025)
 Table 67. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2026-2031)
 Table 68. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2026-2031)
 Table 70. Biokangtai Company Information
 Table 71. Biokangtai Description and Business Overview
 Table 72. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product
 Table 74. Biokangtai Recent Developments/Updates
 Table 75. Sinovac Company Information
 Table 76. Sinovac Description and Business Overview
 Table 77. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sinovac Sabin Inactivated Polio vaccine (sIPV) Product
 Table 79. Sinovac Recent Developments/Updates
 Table 80. Imbcams Company Information
 Table 81. Imbcams Description and Business Overview
 Table 82. Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Imbcams Sabin Inactivated Polio vaccine (sIPV) Product
 Table 84. Imbcams Recent Developments/Updates
 Table 85. Intravacc Company Information
 Table 86. Intravacc Description and Business Overview
 Table 87. Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Intravacc Sabin Inactivated Polio vaccine (sIPV) Product
 Table 89. Intravacc Recent Developments/Updates
 Table 90. Beijing Biological Company Information
 Table 91. Beijing Biological Description and Business Overview
 Table 92. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product
 Table 94. Beijing Biological Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Sabin Inactivated Polio vaccine (sIPV) Distributors List
 Table 98. Sabin Inactivated Polio vaccine (sIPV) Customers List
 Table 99. Sabin Inactivated Polio vaccine (sIPV) Market Trends
 Table 100. Sabin Inactivated Polio vaccine (sIPV) Market Drivers
 Table 101. Sabin Inactivated Polio vaccine (sIPV) Market Challenges
 Table 102. Sabin Inactivated Polio vaccine (sIPV) Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sabin Inactivated Polio vaccine (sIPV)
 Figure 2. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Type: 2024 & 2031
 Figure 4. Vials Product Picture
 Figure 5. Syringes Product Picture
 Figure 6. Global Sabin Inactivated Polio vaccine (sIPV) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Sabin Inactivated Polio vaccine (sIPV) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sabin Inactivated Polio vaccine (sIPV) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales (2020-2031) & (K Units)
 Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Average Price (US$/Unit) & (2020-2031)
 Figure 15. Sabin Inactivated Polio vaccine (sIPV) Report Years Considered
 Figure 16. Sabin Inactivated Polio vaccine (sIPV) Sales Share by Manufacturers in 2024
 Figure 17. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Sabin Inactivated Polio vaccine (sIPV) Players: Market Share by Revenue in Sabin Inactivated Polio vaccine (sIPV) in 2024
 Figure 19. Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2020-2031)
 Figure 22. North America Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2020-2031)
 Figure 34. China Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Sabin Inactivated Polio vaccine (sIPV) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Sabin Inactivated Polio vaccine (sIPV) by Type (2020-2031)
 Figure 56. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Sabin Inactivated Polio vaccine (sIPV) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Sabin Inactivated Polio vaccine (sIPV) by Application (2020-2031)
 Figure 59. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2020-2031)
 Figure 60. Sabin Inactivated Polio vaccine (sIPV) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Inactivated Polio Virus Vaccine Market Research Report 2025
Global Oral Polio Vaccines OPV Market Research Report 2024
Global IPV Vaccine Market Research Report 2025
Global Inactivated Influenza Virus Vaccine Market Research Report 2025
Inactivated Influenza Vaccine Market
Global Viral Vaccines Market Research Report 2025
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Inactivated Influenza Vaccine Market Research Report 2025
Global GP Vaccination Market Research Report 2025
COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025
Global Vaccine Vial Monitor Market Research Report 2025
Global Vaccine Cooler Market Research Report 2025
Global Attenuated Vaccine Market Research Report 2025
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Vaccine Market Research Report 2025
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccination Cart Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions